Plasminogen Activator Inhibitor-1 -675 4G/5G Polymorphism and Polycystic Ovary Syndrome Risk: A Meta Analysis

PURPOSE: Several studies have reported that excessive amounts of plasminogen activator inhibitor-1(PAI-1) might increase the incidence of polycystic ovary syndrome(PCOS), but so far the published results were inconsistent. The aim of this study was to further investigate the association between PAI-...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Liu, Ying, Sun, Mei-Guo, Jiang, Rong, Ding, Rui, Che, Zhen, Chen, Yan-Yan, Yao, Ci-Jiang, Zhu, Xiao-Xia, Cao, Ji-Yu
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2014
Assuntos:
Gonadal Physiology and Disease
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3947070/
https://ncbi.nlm.nih.gov/pubmed/24435452
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10815-013-0171-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados